AARD
Aardvark Therapeutics, Inc.
5.30$
-1.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.4% | 98.4% | 95.7% | 95.5% | |
| 92.9% | 92.4% | 79.5% | 40.2% | |
| 96.1% | 94.8% | 95.0% | 93.9% | |
| 266.6% | 430.3% | 170.5% | 9.0% | |
| 3.6% | 13.1% | 6.4% | 9.0% | |
| 0.6% | 1.1% | 0.4% | 0.4% | |
| 1.5% | 9.8% | 3.0% | 1.8% | |
| -166.6% | -330.3% | -70.5% | 91.0% | |
| -182.2% | -358.2% | -75.3% | -98.9% | |
| 127.6% | 203.0% | 28.0% | 18.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.